OncoTherapy Science, Inc. (TYO:4564)

OncoTherapy Science Ratios and Metrics

Market cap in millions JPY. Fiscal year is April - March.

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	May 11, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Market Capitalization	8,057	8,057	7,606	4,353	9,054	13,292
Market Cap Growth	28.95%	5.92%	74.74%	-51.92%	-31.88%	-38.71%
Enterprise Value	5,968	5,872	6,661	3,755	8,077	11,071
Last Close Price	21.00	21.00	28.00	20.00	47.00	69.00
PS Ratio	9.97	9.97	10.14	7.14	7.98	11.53
PB Ratio	3.76	3.76	10.45	12.33	10.60	6.72
P/TBV Ratio	3.76	3.76	10.45	12.33	10.60	6.72
PEG Ratio	-	0.76	0.76	0.76	0.76	0.76
EV/Sales Ratio	7.39	7.27	8.88	6.16	7.12	9.60
Net Debt / Equity Ratio	-0.98	-0.98	-1.14	-1.49	-1.31	-0.93
Net Debt / EBITDA Ratio	-	-	-	-	1.02	0.90
Net Debt / FCF Ratio	-	-	1.02	0.43	1.40	0.73
Asset Turnover	0.46	0.46	0.74	0.51	0.54	0.38
Inventory Turnover	19.11	19.11	16.60	17.04	10.97	20.37
Quick Ratio	12.97	12.97	2.85	1.99	2.04	3.70
Current Ratio	13.66	13.66	3.38	2.28	2.34	4.31
Return on Equity (ROE)	-63.44%	-63.44%	-150.79%	-213.42%	-78.93%	-101.74%
Return on Assets (ROA)	-28.78%	-28.78%	-49.27%	-58.87%	-32.98%	-42.40%
Return on Capital Employed (ROCE)	-36.90%	-36.90%	-96.30%	-220.50%	-122.70%	-98.70%
Earnings Yield	-11.30%	-11.29%	-10.71%	-29.59%	-12.35%	-19.34%
FCF Yield	-	-	-10.71%	-28.23%	-8.81%	-19.03%
Buyback Yield / Dilution	-25.69%	-25.69%	-22.73%	-10.45%	-2.76%	-6.31%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.